T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Vaxcyte
PCVX
$8.76B
| $206K | ﹤0.01% |
8,551
-5,377
| -39% | -$136K |
|
|
MNRL
2527
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $205K | ﹤0.01% |
+8,293
| New | +$222K |
|
2528
Triumph Financial Inc
TFIN
$1.87B
| $204K | ﹤0.01% |
+3,737
| New | +$246K |
|
|
SAFE
2529
DELISTED
Safehold Inc.
SAFE
| $204K | ﹤0.01% |
7,674
-1,789,837
| -100% | -$69.7M |
|
2530
Syndax Pharmaceuticals
SNDX
$1.7B
| $203K | ﹤0.01% |
+8,429
| New | +$189K |
|
2531
Kartoon Studios
TOON
$38.2M
| $203K | ﹤0.01% |
33,740
+4,830
| +17% | +$35.5K |
|
2532
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $202K | ﹤0.01% |
3,400
| – | – |
|
2533
Northrim BanCorp
NRIM
$601M
| $201K | ﹤0.01% |
+19,300
| New | +$198K |
|
2534
SiriusPoint
SPNT
$2.7B
| $201K | ﹤0.01% |
40,480
+5,777
| +17% | +$26.8K |
|
2535
American Superconductor
AMSC
$1.53B
| $200K | ﹤0.01% |
45,600
+21,600
| +90% | +$112K |
|
|
AVDX
2536
DELISTED
AvidXchange
AVDX
| $200K | ﹤0.01% |
23,713
+9,724
| +70% | +$75.3K |
|
|
BHR
2537
Braemar Hotels & Resorts
BHR
$139M
| $200K | ﹤0.01% |
46,481
+10,658
| +30% | +$54K |
|
|
CPRX
2538
DELISTED
Catalyst Pharmaceutical
CPRX
| $199K | ﹤0.01% |
+15,458
| New | +$183K |
|
2539
MediaAlpha
MAX
$813M
| $199K | ﹤0.01% |
22,730
-2,432
| -10% | -$23.7K |
|
2540
Mercer International
MERC
$33.8M
| $199K | ﹤0.01% |
16,148
-12,077
| -43% | -$179K |
|
|
SWI
2541
DELISTED
SolarWinds Corporation Common Stock
SWI
| $199K | ﹤0.01% |
25,653
+2,896
| +13% | +$27.8K |
|
2542
Flexsteel Industries
FLXS
$303M
| $198K | ﹤0.01% |
12,600
+1,400
| +13% | +$24.4K |
|
|
SELF
2543
Global Self Storage
SELF
$58.9M
| $196K | ﹤0.01% |
33,399
| – | – |
|
|
QUOT
2544
DELISTED
Quotient Technology Inc
QUOT
| $196K | ﹤0.01% |
84,468
-5,730
| -6% | -$14.1K |
|
|
MYOV
2545
DELISTED
Myovant Sciences Ltd.
MYOV
| $196K | ﹤0.01% |
10,900
| – | – |
|
|
ALEX
2546
DELISTED
Alexander & Baldwin
ALEX
| $195K | ﹤0.01% |
11,703
-24,621
| -68% | -$453K |
|
2547
Heron Therapeutics
HRTX
$63.5M
| $195K | ﹤0.01% |
46,119
+14,351
| +45% | +$56.2K |
|
2548
BioXcel Therapeutics
BTAI
$34.9M
| $194K | ﹤0.01% |
1,025
+103
| +11% | +$23.9K |
|
2549
Rimini Street
RMNI
$470M
| $194K | ﹤0.01% |
41,586
+3,668
| +10% | +$20.6K |
|
2550
Oric Pharmaceuticals
ORIC
$1.42B
| $191K | ﹤0.01% |
59,339
+6,900
| +13% | +$27.6K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.